Vanessa V. Longacre, APRN

Vanessa Longacre practices at Baptist Primary Care Inc in Jacksonville, Florida.

Vanessa Longacre's NPI, 1841262011, was assigned on February 2, 2006. Vanessa Longacre holds Florida license APRN9493697.

Vanessa Longacre's primary practice is Baptist Primary Care Inc, at 524 Skymarks Dr, Jacksonville, FL 32218 in Duval County. The practice phone is (904) 376-3707.

Vanessa Longacre's primary practice is Baptist Primary Care Inc in Jacksonville, Florida. Vanessa Longacre is also affiliated with Baptist Medical Center Jacksonville. The medical group on file is Baptist Primary Care. Dmand AI also links Vanessa Longacre to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Vanessa Longacre practices, 3 sites in all. Vendor and product names are available with a free account.

Nurse practitioner is Vanessa Longacre's primary specialty in the NPI Registry, under taxonomy code 363L00000X. Dmand AI has Vanessa Longacre's licenses on file in 3 states: Florida, Indiana and Kentucky.

Dmand AI lists acute sinusitis, acute skin infection, adjustment disease, bursitis, conjunctivitis, fibromyalgia and chronic pain, fluid and electrolyte imbalances and gastroenteritis among the conditions Vanessa Longacre treats.

CMS data shows 164 Medicare services from Vanessa Longacre across 3 procedure codes in 2024, for 170 Medicare patients. Medicare paid $7,719 for them.

CMS counts 170 Medicare patients who saw Vanessa Longacre in 2024. The largest group is 65 to 74, with 68 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 1.32, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Vanessa Longacre's median patient age at 68, with 72% women.

In 2024, Vanessa Longacre wrote 539 Medicare Part D claims for 336 patients. 89% of them were for generic drugs. CMS names the drug for 210 of them, across 13 drugs with 11 or more claims each, at $2,180 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Vanessa Longacre for performance year 2024, reported through an alternative payment model (APM). Vanessa Longacre accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Vanessa Longacre as offering telehealth.

CMS Open Payments shows 26 general payments to Vanessa Longacre from 12 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Novo Nordisk Inc paid the most, $242.